FUKUDA DENSHI, a supplier of advanced patient monitoring and user-configurable clinical information management systems, as well as cardiology and imaging technology, has announced the launch of the VaSera VS2000 – a cutting-edge vascular screening device with an array of features including CAVI (Cardio Ankle Vascular Index) and ABI (Ankle Brachial Index).
CAVI is an arteriosclerosis index that measures the degree of arterial stiffness between the heart and ankle, and is independent from fluctuations in blood pressure. It provides a consistent result that can help to predict arteriosclerosis and future cardiovascular complications. Measuring a patient’s CAVI is quick and easy, and is not dependent on a qualified technician. Measurement can be undertaken by trained personnel, and a comprehensive report of the key parameters is available in less than ten minutes.
